25 XP   0   0   10

Guizhou Bailing Group Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Guizhou Bailing Group Pharmaceutical Co Ltd together

PenkeI guess you are interested in Guizhou Bailing Group Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guizhou Bailing Group Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guizhou Bailing Group Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guizhou Bailing Group Pharmaceutical Co Ltd.

Quick analysis of Guizhou Bailing Group Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Guizhou Bailing Group Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥2.83
Expected worth in 1 year
¥2.94
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.35
Return On Investment
5.3%

For what price can you sell your share?

Current Price per Share
¥6.54
Expected price per share
¥6.11 - ¥7.56
How sure are you?
50%

1. Valuation of Guizhou Bailing Group Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.54

Intrinsic Value Per Share

¥1.33 - ¥4.12

Total Value Per Share

¥4.16 - ¥6.96

2. Growth of Guizhou Bailing Group Pharmaceutical Co Ltd (5 min.)




Is Guizhou Bailing Group Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$552.3m$547.2m$5m0.9%

How much money is Guizhou Bailing Group Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$19m$17.1m$1.9m10.1%
Net Profit Margin3.9%4.0%--

How much money comes from the company's main activities?

3. Financial Health of Guizhou Bailing Group Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Guizhou Bailing Group Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Guizhou Bailing Group Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Guizhou Bailing Group Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Guizhou Bailing Group Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Guizhou Bailing Group Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guizhou Bailing Group Pharmaceutical Co Ltd is ¥6.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guizhou Bailing Group Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guizhou Bailing Group Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.83. Based on the TTM, the Book Value Change Per Share is ¥0.03 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guizhou Bailing Group Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%0.010.2%0.020.4%0.030.5%
Usd Book Value Change Per Share0.000.1%0.000.1%0.000.1%0.010.2%0.020.3%
Usd Dividend Per Share0.010.1%0.010.1%0.010.2%0.020.3%0.020.3%
Usd Total Gains Per Share0.010.2%0.010.2%0.010.2%0.030.5%0.040.6%
Usd Price Per Share1.13-1.13-1.05-1.13-2.31-
Price to Earnings Ratio83.33-83.33-90.52-62.35-81.58-
Price-to-Total Gains Ratio93.42-93.42-76.55-54.34-70.38-
Price to Book Ratio2.88-2.88-2.71-2.90-8.45-
Price-to-Total Gains Ratio93.42-93.42-76.55-54.34-70.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.903828
Number of shares1106
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.03
Gains per Quarter (1106 shares)13.3532.91
Gains per Year (1106 shares)53.40131.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13716438646122
275329617292254
311248149257138386
415064202343184518
518780255429229650
622595308515275782
7262111361600321914
83001274146863671046
93371434677724131178
103751595208584591310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%12.01.00.092.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%

Fundamentals of Guizhou Bailing Group Pharmaceutical Co Ltd

About Guizhou Bailing Group Pharmaceutical Co Ltd

Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China.

Fundamental data was last updated by Penke on 2024-04-14 16:12:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Guizhou Bailing Group Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guizhou Bailing Group Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.9% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 3.9%. The company is making a profit. +1
  • The TTM is 3.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY4.0%-0.1%
TTM3.9%5Y8.2%-4.3%
5Y8.2%10Y14.4%-6.2%
1.1.2. Return on Assets

Shows how efficient Guizhou Bailing Group Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.0% Return on Assets means that Guizhou Bailing Group Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY1.9%+0.1%
TTM2.0%5Y3.9%-1.9%
5Y3.9%10Y6.9%-3.0%
1.1.3. Return on Equity

Shows how efficient Guizhou Bailing Group Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.5% Return on Equity means Guizhou Bailing Group Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 3.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%0.0%
TTM3.5%YOY3.2%+0.3%
TTM3.5%5Y6.5%-3.0%
5Y6.5%10Y10.5%-4.1%

1.2. Operating Efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guizhou Bailing Group Pharmaceutical Co Ltd is operating .

  • Measures how much profit Guizhou Bailing Group Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 5.7% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 5.7%. The company is operating less efficient.
  • The TTM is 5.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.7%TTM5.7%0.0%
TTM5.7%YOY7.2%-1.4%
TTM5.7%5Y11.1%-5.4%
5Y11.1%10Y13.5%-2.4%
1.2.2. Operating Ratio

Measures how efficient Guizhou Bailing Group Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are ¥1.31 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 1.307. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.307. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.307TTM1.3070.000
TTM1.307YOY1.303+0.004
TTM1.3075Y1.267+0.041
5Y1.26710Y1.038+0.229

1.3. Liquidity of Guizhou Bailing Group Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guizhou Bailing Group Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.38 means the company has ¥1.38 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 1.380. The company is just able to pay all its short-term debts.
  • The TTM is 1.380. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.380TTM1.3800.000
TTM1.380YOY1.446-0.067
TTM1.3805Y1.625-0.245
5Y1.62510Y1.631-0.006
1.3.2. Quick Ratio

Measures if Guizhou Bailing Group Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.55 means the company can pay off ¥0.55 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 0.554. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.554. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.554TTM0.5540.000
TTM0.554YOY0.899-0.345
TTM0.5545Y0.809-0.255
5Y0.80910Y0.924-0.114

1.4. Solvency of Guizhou Bailing Group Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guizhou Bailing Group Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.42 means that Guizhou Bailing Group Pharmaceutical Co Ltd assets are financed with 42.0% credit (debt) and the remaining percentage (100% - 42.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 0.420. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.420. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.420TTM0.4200.000
TTM0.420YOY0.390+0.031
TTM0.4205Y0.402+0.019
5Y0.40210Y0.360+0.042
1.4.2. Debt to Equity Ratio

Measures if Guizhou Bailing Group Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 72.5% means that company has ¥0.73 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The MRQ is 0.725. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.725. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.725TTM0.7250.000
TTM0.725YOY0.642+0.084
TTM0.7255Y0.683+0.043
5Y0.68310Y0.580+0.103

2. Market Valuation of Guizhou Bailing Group Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guizhou Bailing Group Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guizhou Bailing Group Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 83.33 means the investor is paying ¥83.33 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The EOD is 66.783. Based on the earnings, the company is expensive. -2
  • The MRQ is 83.326. Based on the earnings, the company is expensive. -2
  • The TTM is 83.326. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD66.783MRQ83.326-16.543
MRQ83.326TTM83.3260.000
TTM83.326YOY90.521-7.195
TTM83.3265Y62.351+20.974
5Y62.35110Y81.578-19.226
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The EOD is 21.280. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 26.552. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 26.552. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD21.280MRQ26.552-5.271
MRQ26.552TTM26.5520.000
TTM26.552YOY-106.395+132.946
TTM26.5525Y-1.885+28.436
5Y-1.88510Y-34.481+32.596
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guizhou Bailing Group Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Guizhou Bailing Group Pharmaceutical Co Ltd:

  • The EOD is 2.309. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.881. Based on the equity, the company is underpriced. +1
  • The TTM is 2.881. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.309MRQ2.881-0.572
MRQ2.881TTM2.8810.000
TTM2.881YOY2.708+0.173
TTM2.8815Y2.904-0.023
5Y2.90410Y8.450-5.546
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guizhou Bailing Group Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0260.0260%0.028-8%0.075-65%0.138-81%
Book Value Per Share--2.8322.8320%2.806+1%2.827+0%2.383+19%
Current Ratio--1.3801.3800%1.446-5%1.625-15%1.631-15%
Debt To Asset Ratio--0.4200.4200%0.390+8%0.402+5%0.360+17%
Debt To Equity Ratio--0.7250.7250%0.642+13%0.683+6%0.580+25%
Dividend Per Share--0.0610.0610%0.071-14%0.140-56%0.129-52%
Eps--0.0980.0980%0.084+17%0.178-45%0.231-58%
Free Cash Flow Per Share--0.3070.3070%-0.071+123%0.076+306%0.055+455%
Free Cash Flow To Equity Per Share--0.3070.3070%-0.615+300%0.077+300%0.044+599%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.124--------
Intrinsic Value_10Y_min--1.327--------
Intrinsic Value_1Y_max--0.177--------
Intrinsic Value_1Y_min--0.091--------
Intrinsic Value_3Y_max--0.713--------
Intrinsic Value_3Y_min--0.311--------
Intrinsic Value_5Y_max--1.465--------
Intrinsic Value_5Y_min--0.572--------
Market Cap9229248000.000-25%11515392000.00011515392000.0000%10725120000.000+7%11585952000.000-1%23630544000.000-51%
Net Profit Margin--0.0390.0390%0.040-2%0.082-52%0.144-73%
Operating Margin--0.0570.0570%0.072-20%0.111-48%0.135-58%
Operating Ratio--1.3071.3070%1.303+0%1.267+3%1.038+26%
Pb Ratio2.309-25%2.8812.8810%2.708+6%2.904-1%8.450-66%
Pe Ratio66.783-25%83.32683.3260%90.521-8%62.351+34%81.578+2%
Price Per Share6.540-25%8.1608.1600%7.600+7%8.210-1%16.745-51%
Price To Free Cash Flow Ratio21.280-25%26.55226.5520%-106.395+501%-1.885+107%-34.481+230%
Price To Total Gains Ratio74.876-25%93.42393.4230%76.553+22%54.342+72%70.384+33%
Quick Ratio--0.5540.5540%0.899-38%0.809-32%0.924-40%
Return On Assets--0.0200.0200%0.019+5%0.039-49%0.069-71%
Return On Equity--0.0350.0350%0.032+10%0.065-46%0.105-67%
Total Gains Per Share--0.0870.0870%0.099-12%0.215-59%0.267-67%
Usd Book Value--552372257.560552372257.5600%547299005.326+1%551332431.459+0%464845436.155+19%
Usd Book Value Change Per Share--0.0040.0040%0.004-8%0.010-65%0.019-81%
Usd Book Value Per Share--0.3910.3910%0.388+1%0.391+0%0.329+19%
Usd Dividend Per Share--0.0080.0080%0.010-14%0.019-56%0.018-52%
Usd Eps--0.0140.0140%0.012+17%0.025-45%0.032-58%
Usd Free Cash Flow--59937347.84759937347.8470%-13931271.076+123%14751449.314+306%6480206.647+825%
Usd Free Cash Flow Per Share--0.0420.0420%-0.010+123%0.010+306%0.008+455%
Usd Free Cash Flow To Equity Per Share--0.0420.0420%-0.085+300%0.011+300%0.006+599%
Usd Market Cap1275482073.600-25%1591427174.4001591427174.4000%1482211584.000+7%1601178566.400-1%3265741180.800-51%
Usd Price Per Share0.904-25%1.1281.1280%1.050+7%1.135-1%2.314-51%
Usd Profit--19098888.46819098888.4680%17165341.989+11%35086283.790-46%45182051.581-58%
Usd Revenue--489246280.097489246280.0970%430029967.509+14%434552641.269+13%351124642.308+39%
Usd Total Gains Per Share--0.0120.0120%0.014-12%0.030-59%0.037-67%
 EOD+4 -4MRQTTM+0 -0YOY+19 -165Y+12 -2310Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of Guizhou Bailing Group Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1566.783
Price to Book Ratio (EOD)Between0-12.309
Net Profit Margin (MRQ)Greater than00.039
Operating Margin (MRQ)Greater than00.057
Quick Ratio (MRQ)Greater than10.554
Current Ratio (MRQ)Greater than11.380
Debt to Asset Ratio (MRQ)Less than10.420
Debt to Equity Ratio (MRQ)Less than10.725
Return on Equity (MRQ)Greater than0.150.035
Return on Assets (MRQ)Greater than0.050.020
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Guizhou Bailing Group Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.074
Ma 20Greater thanMa 507.255
Ma 50Greater thanMa 1007.491
Ma 100Greater thanMa 2007.772
OpenGreater thanClose6.590
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,894,399
Total Liabilities2,897,494
Total Stockholder Equity3,994,636
 As reported
Total Liabilities 2,897,494
Total Stockholder Equity+ 3,994,636
Total Assets = 6,894,399

Assets

Total Assets6,894,399
Total Current Assets3,819,847
Long-term Assets3,074,552
Total Current Assets
Cash And Cash Equivalents 605,023
Net Receivables 1,534,084
Inventory 804,826
Other Current Assets 4,024
Total Current Assets  (as reported)3,819,847
Total Current Assets  (calculated)2,947,958
+/- 871,889
Long-term Assets
Property Plant Equipment 1,057,185
Goodwill 20,584
Intangible Assets 327,987
Long-term Assets Other 83,756
Long-term Assets  (as reported)3,074,552
Long-term Assets  (calculated)1,489,511
+/- 1,585,041

Liabilities & Shareholders' Equity

Total Current Liabilities2,768,402
Long-term Liabilities129,092
Total Stockholder Equity3,994,636
Total Current Liabilities
Short Long Term Debt 1,480,588
Accounts payable 581,277
Other Current Liabilities 562,797
Total Current Liabilities  (as reported)2,768,402
Total Current Liabilities  (calculated)2,624,662
+/- 143,740
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt47,279
Long-term Liabilities  (as reported)129,092
Long-term Liabilities  (calculated)47,279
+/- 81,813
Total Stockholder Equity
Retained Earnings 2,173,971
Total Stockholder Equity (as reported)3,994,636
Total Stockholder Equity (calculated)2,173,971
+/- 1,820,665
Other
Capital Stock1,411,200
Common Stock Shares Outstanding 1,411,200
Net Debt 875,565
Net Invested Capital 5,475,223
Net Tangible Assets 3,768,950
Net Working Capital 1,051,445
Property Plant and Equipment Gross 1,057,185



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
2,799,514
3,018,820
3,240,031
3,479,169
3,565,181
3,841,513
4,235,956
4,822,671
5,976,300
7,058,918
7,032,834
6,489,334
6,894,399
6,894,3996,489,3347,032,8347,058,9185,976,3004,822,6714,235,9563,841,5133,565,1813,479,1693,240,0313,018,8202,799,514
   > Total Current Assets 
0
0
0
0
0
2,905,884
3,211,040
3,649,475
3,996,078
4,581,765
4,595,047
3,503,252
3,819,847
3,819,8473,503,2524,595,0474,581,7653,996,0783,649,4753,211,0402,905,88400000
       Cash And Cash Equivalents 
1,318,940
1,099,165
940,959
720,321
661,785
960,788
1,217,387
1,000,141
545,546
1,136,888
1,030,960
465,625
605,023
605,023465,6251,030,9601,136,888545,5461,000,1411,217,387960,788661,785720,321940,9591,099,1651,318,940
       Short-term Investments 
0
0
0
0
100,000
0
0
0
0
0
0
0
0
00000000100,0000000
       Net Receivables 
602,103
555,354
683,161
954,040
1,048,513
1,226,702
1,249,630
1,704,327
2,431,781
2,311,083
1,504,486
2,177,584
1,534,084
1,534,0842,177,5841,504,4862,311,0832,431,7811,704,3271,249,6301,226,7021,048,513954,040683,161555,354602,103
       Inventory 
307,972
620,816
657,938
734,150
726,015
632,314
680,386
826,103
869,085
1,006,947
783,541
825,128
804,826
804,826825,128783,5411,006,947869,085826,103680,386632,314726,015734,150657,938620,816307,972
   > Long-term Assets 
0
0
0
0
0
0
1,024,916
1,173,197
1,980,223
2,477,153
2,437,787
2,959,007
3,074,552
3,074,5522,959,0072,437,7872,477,1531,980,2231,173,1971,024,916000000
       Property Plant Equipment 
184,511
412,373
602,454
681,485
675,392
633,429
675,787
718,813
748,841
715,323
670,550
954,553
1,057,185
1,057,185954,553670,550715,323748,841718,813675,787633,429675,392681,485602,454412,373184,511
       Goodwill 
0
0
0
0
32,847
20,584
20,584
20,584
20,584
20,584
20,584
20,584
20,584
20,58420,58420,58420,58420,58420,58420,58420,58432,8470000
       Long Term Investments 
0
0
0
0
0
8,842
8,842
88,842
836,338
0
0
0
0
0000836,33888,8428,8428,84200000
       Intangible Assets 
4,697
112,420
102,042
91,658
217,672
178,706
238,498
264,453
271,484
319,609
244,034
334,006
327,987
327,987334,006244,034319,609271,484264,453238,498178,706217,67291,658102,042112,4204,697
       Long-term Assets Other 
0
0
0
0
0
0
0
1,173,197
1,980,223
14,000
30,055
54,291
83,756
83,75654,29130,05514,0001,980,2231,173,1970000000
> Total Liabilities 
952,491
1,078,453
1,197,487
1,351,790
1,217,274
1,160,537
1,170,615
1,355,475
2,051,551
2,914,143
3,112,556
2,529,139
2,897,494
2,897,4942,529,1393,112,5562,914,1432,051,5511,355,4751,170,6151,160,5371,217,2741,351,7901,197,4871,078,453952,491
   > Total Current Liabilities 
820,478
831,528
1,087,088
1,308,418
1,176,982
1,122,063
1,130,396
1,324,674
2,022,553
2,667,345
2,863,019
2,422,139
2,768,402
2,768,4022,422,1392,863,0192,667,3452,022,5531,324,6741,130,3961,122,0631,176,9821,308,4181,087,088831,528820,478
       Short-term Debt 
0
0
0
0
0
0
801,600
861,600
1,581,600
0
0
0
0
00001,581,600861,600801,600000000
       Short Long Term Debt 
0
0
0
0
0
0
801,600
861,600
1,581,600
2,201,919
2,062,989
1,447,600
1,480,588
1,480,5881,447,6002,062,9892,201,9191,581,600861,600801,600000000
       Accounts payable 
132,228
133,945
106,989
140,903
123,176
157,784
178,123
248,172
193,329
243,802
558,354
403,881
581,277
581,277403,881558,354243,802193,329248,172178,123157,784123,176140,903106,989133,945132,228
       Other Current Liabilities 
118,850
132,183
90,699
156,915
301,880
139,668
108,029
141,200
135,613
155,094
172,047
262,429
562,797
562,797262,429172,047155,094135,613141,200108,029139,668301,880156,91590,699132,183118,850
   > Long-term Liabilities 
0
0
0
0
0
0
40,219
30,801
28,998
245,444
249,537
174,541
129,092
129,092174,541249,537245,44428,99830,80140,219000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-801,600
-861,600
-1,581,600
0
65,376
57,656
47,279
47,27957,65665,3760-1,581,600-861,600-801,600000000
       Long-term Liabilities Other 
0
0
0
0
0
0
20,680
0
0
212,851
0
0
0
000212,8510020,680000000
       Deferred Long Term Liability 
0
0
0
0
0
34,468
92,778
121,138
155,444
197,723
154,849
149,177
0
0149,177154,849197,723155,444121,13892,77834,46800000
> Total Stockholder Equity
1,847,023
1,914,351
2,024,397
2,105,841
2,321,794
2,646,789
3,021,610
3,419,807
3,870,150
4,060,543
3,893,860
3,941,295
3,994,636
3,994,6363,941,2953,893,8604,060,5433,870,1503,419,8073,021,6102,646,7892,321,7942,105,8412,024,3971,914,3511,847,023
   Common Stock
235,200
470,400
470,400
470,400
470,400
1,411,200
1,411,200
1,411,200
1,411,200
1,411,200
1,411,200
1,411,200
0
01,411,2001,411,2001,411,2001,411,2001,411,2001,411,2001,411,200470,400470,400470,400470,400235,200
   Retained Earnings 
246,685
300,606
414,681
474,082
772,718
1,090,013
1,459,444
1,872,685
2,323,028
2,504,749
2,346,660
2,404,430
2,173,971
2,173,9712,404,4302,346,6602,504,7492,323,0281,872,6851,459,4441,090,013772,718474,082414,681300,606246,685
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
37
78
78
0
0787837000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,251,148
Cost of Revenue-1,838,659
Gross Profit2,412,4892,412,489
 
Operating Income (+$)
Gross Profit2,412,489
Operating Expense-3,853,547
Operating Income397,601-1,441,058
 
Operating Expense (+$)
Research Development32,409
Selling General Administrative1,821,980
Selling And Marketing Expenses-
Operating Expense3,853,5471,854,390
 
Net Interest Income (+$)
Interest Income1,334
Interest Expense-113,051
Other Finance Cost-8,325
Net Interest Income-103,391
 
Pretax Income (+$)
Operating Income397,601
Net Interest Income-103,391
Other Non-Operating Income Expenses-
Income Before Tax (EBT)199,716397,601
EBIT - interestExpense = -113,051
178,485
291,536
Interest Expense113,051
Earnings Before Interest and Taxes (EBIT)-312,767
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax199,716
Tax Provision-25,933
Net Income From Continuing Ops173,783173,783
Net Income178,485
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-103,391
 

Technical Analysis of Guizhou Bailing Group Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guizhou Bailing Group Pharmaceutical Co Ltd. The general trend of Guizhou Bailing Group Pharmaceutical Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guizhou Bailing Group Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guizhou Bailing Group Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6.56 < 7.29 < 7.56.

The bearish price targets are: 6.37 > 6.14 > 6.11.

Tweet this
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guizhou Bailing Group Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guizhou Bailing Group Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current macd is -0.26089164.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guizhou Bailing Group Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Guizhou Bailing Group Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Guizhou Bailing Group Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current adx is 30.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Guizhou Bailing Group Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guizhou Bailing Group Pharmaceutical Co Ltd. The current sar is 7.034826.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current rsi is 25.07. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guizhou Bailing Group Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guizhou Bailing Group Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current cci is -180.24691358.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current cmo is -59.66599003.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guizhou Bailing Group Pharmaceutical Co Ltd. The current willr is -93.69369369.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Williams %R ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guizhou Bailing Group Pharmaceutical Co Ltd.

Guizhou Bailing Group Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current atr is 0.1978616.

Guizhou Bailing Group Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current obv is 1,154,925,376.

Guizhou Bailing Group Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guizhou Bailing Group Pharmaceutical Co Ltd. The current mfi is 33.20.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guizhou Bailing Group Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartGuizhou Bailing Group Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guizhou Bailing Group Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Guizhou Bailing Group Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guizhou Bailing Group Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.074
Ma 20Greater thanMa 507.255
Ma 50Greater thanMa 1007.491
Ma 100Greater thanMa 2007.772
OpenGreater thanClose6.590
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guizhou Bailing Group Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guizhou Bailing Group Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guizhou Bailing Group Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guizhou Bailing Group Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guizhou Bailing Group Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guizhou Bailing Group Pharmaceutical Co Ltd.

Receive notifications about Guizhou Bailing Group Pharmaceutical Co Ltd in your mailbox!